EUVIMEDEUVIMED entdecken
Crossref

Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits

Brian Dean, Vahram Haroutunian, Elizabeth Scarr

Schizophrenia Research · 2023

DOI: 10.1016/j.schres.2023.03.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research, 2023. Verfasst von Brian Dean und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Synaptic Biology and Cognition Laboratory, The Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia; Florey Depart…. Hauptthemen laut MEDLINE: Schizophrenia, Cognition Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 87 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple lines of evidence argue for lower levels of cortical muscarinic M1 receptors (CHRM1) in people with schizophrenia which is possibly due to a sub-group within the disorder who have a marked loss of CHRM1 (muscarinic receptor deficit sub-group (MRDS)). In this study we sought to determine if the lower levels of CHRM1 was apparent in older people with schizophrenia and whether the loss of CHRM1 was associated with symptom severity by measuring levels of cortical [3H]pirenzepine binding to CHRM1 from 56 people with schizophrenia and 43 controls. Compared to controls (173 ± 6.3 fmol / mg protein), there were lower levels of cortical [3H]pirenzepine binding in the people with schizophrenia (mean ± SEM: 153 ± 6.0 fmol / mg protein; p = 0.02; Cohen's d = - 0.46). [3H]pirenzepine binding in the people with schizophrenia, but not controls, was not normally distributed and best fitted a two-population solution. The nadir of binding separating the two groups of people with schizophrenia was 121 fmol / mg protein and levels of [3H]pirenzepine binding below this value had a 90.7 % specificity for the disorder. Compared to controls, the score from the Clinical Dementia Rating Scale (CDR) did not differ significantly in MRDS but were significantly higher in the sub-group with normal radioligand binding. Positive and Negative Syndrome Scale scores did not differ between the two sub-groups with schizophrenia. Our current study replicates and earlier finding showing a MRDS within schizophrenia and, for the first time, suggest this sub-group have less severe cognitive deficits others with schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaCognition DisordersHumansAgedPirenzepineReceptor, Muscarinic M1Cognition

Stichwörter der Autor:innen

CortexMuscarinic M1 receptorSchizophreniaSub-groupSymptom ratings

Substanzen

PirenzepineReceptor, Muscarinic M1CHRM1 protein, human

Autor:innen und Institutionen

  • The Synaptic Biology and Cognition Laboratory, The Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia; Florey Department of Neuroscience and Mental Health, the University of Melbourne, P…
  • Departments of Psychiatry and Neuroscience, The Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Mental Illness Research, Education and Clinical Centers, JJ Peters VA Medical Center, Bronx, NY, USA.
  • Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia.

Zitieren

APA

Dean, B., Haroutunian, V., & Scarr, E. (2023). Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits. Schizophrenia Research. https://doi.org/10.1016/j.schres.2023.03.035

Vancouver

Dean B, Haroutunian V, Scarr E. Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits. Schizophrenia Research. 2023. doi:10.1016/j.schres.2023.03.035

BibTeX
@article{Dean2023,
  author = {Dean, Brian and Haroutunian, Vahram and Scarr, Elizabeth},
  title = {Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits},
  journal = {Schizophrenia Research},
  year = {2023},
  doi = {10.1016/j.schres.2023.03.035}
}
Kostenlos starten →